An official website of the United States government
Rates* of reported cases† of acute hepatitis B virus infection, by age group — United States, 2005-2020
Downloads of this figure: PDF PPT
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported confirmed cases. For the case definition, see Acute Hepatitis B.
During 2011–2019, rates of reported cases of acute hepatitis B remained low among children and adolescents aged 0–19 years and among persons aged 20–29 years, likely explained, in part, because of the implementation of childhood hepatitis B vaccine recommendations published in 1991. As the cohort of persons vaccinated as children has grown older, rates of acute hepatitis B among persons aged 30–39 years began to consistently decrease beginning in 2015.
Conversely, between 2011 and 2019 rates of reported cases of acute hepatitis B steadily increased among persons aged 40–49 and 50–59 years. In 2020, rates declined in all adult age groups and remained at 0.0 cases per 100,000 population among those 0-19 years of age. In 2020, the highest rates were among persons 40-49 years (1.7 cases per 100,000 population), 50-59-years (1.2 cases per 100,000 population), and 30-39 years (1.0 cases per 100,000 population).
- Figure 2.1. Number of reported cases of acute hepatitis B virus infection and estimated infections — United States, 2013-2020
- Figure 2.2. Rates of reported acute hepatitis B virus infection†, by state or jurisdiction — United States, 2019-2020
- Figure 2.3. Rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2020
- Figure 2.4. Rates of reported cases of acute hepatitis B virus infection, by age group — United States, 2005-2020
- Figure 2.5. Rates of reported cases of acute hepatitis B virus infection, by sex — United States, 2005-2020
- Figure 2.6. Rates of reported cases of acute hepatitis B virus infection, by race/ethnicity — United States, 2005-2020
- Figure 2.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis B virus infection — United States, 2020
- Figure 2.8. Rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2020
- Table 2.1. Numbers and rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2016-2020
- Table 2.2. Numbers and rates of reported cases of acute hepatitis B virus infection, by demographic characteristics — United States 2016-2020
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B virus infection — United States, 2020
- Table 2.4. Number of newly reported cases of perinatal hepatitis B virus infection, by state or jurisdiction — United States, 2020
- Table 2.5. Number and rate of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2020
- Table 2.6. Number and rate of newly reported cases of chronic hepatitis B virus infection, by demographic characteristics — United States, 2020
- Table 2.7. Numbers and rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2016-2020
- Table 2.8. Numbers and rates of deaths with hepatitis B virus infections listed as a cause of death among residents, by demographic characteristics — United States, 2016-2020
Source:
- Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2018;67(No. RR-1):1–31.